Press Release — Responsum Health Named A “Deal to Watch,” Receives Coveted 5-Star Rating, in New Report from Leading Startup Analyst KingsCrowd

Responsum Health Named A “Deal to Watch,” Receives Coveted 5-Star Rating, in New Report from Leading Startup Analyst KingsCrowd

The rating places Responsum Health in the top 0.5% out of more than 700 active equity crowdfunding campaigns currently rated by KingsCrowd

​[WASHINGTON, D.C., January 27, 2022]A new report published this week by one of the country’s most respected startup analytics firms, KingsCrowd, offered a glowing assessment of Responsum’s prospects. Currently, Responsum Health is raising funds from interested investors on the private investing platform site Republic to fuel an aggressive business development plan.

The report takes a hard look at Responsum’s market viability/differentiation, performance, team, risks, and several other factors. The result was an exceedingly rare 5.0 Star rating overall.

“We’re grateful to KingsCrowd for taking such a deep and thorough look at our company,” says Responsum Health Founder and CEO Andrew Rosenberg. “This report provides support for our corporate mission, confirms the strength of our leadership team, and validates the viability of our business model.”

Responsum Health looks forward to leveraging the findings in this report to grow our investor community, and enrich our network of supporters and partners. Click here to view the full report. For more information on our Republic fundraising efforts and to become an investor, click here.

About Responsum Health

With a mission of building and supporting online “knowledge communities” of chronic disease patients, Responsum Health (Latin for “the answer”) is a disruptive and innovative healthcare startup company that develops and provides free, disease-specific patient engagement platforms and apps that monitor, search, and curate the Internet – and then generate a personalized newsfeed of article summaries vetted by Responsum’s patient group and subject matter expert partners. For patients with chronic illness, Responsum Health replaces the need to sort and sift through the Internet on their own with a professionalized search and summary service; indeed, no other such app or platform exists.

Responsum Health wraps a proprietary newsfeed into a highly engaging digital platform that enables patients to comment on and rate the articles and share with their professional care team and loved ones. Responsum platforms also enable patients to share experiences through a moderated social wall, organize their health information, and find local patient support groups and services near them.

With dynamic patient knowledge platforms in areas as diverse as pulmonary fibrosis, chronic kidney disease, uterine fibroids, glaucoma, and long COVID, Responsum Health’s apps drive extremely high user engagement metrics that widely exceed industry standards. Developed from years of interviews, extensive research at Carnegie Mellon University, and collaboration with hundreds of patients worldwide, Responsum Health’s disease-specific apps are designed to improve patients’ knowledge, grow their self-confidence, and provide for the organization and coordination of their healthcare information. Today, thousands of patients and their caregivers rely on Responsum Health apps and content for their daily health information.

The company is a part of the Startup Health network of recognized healthcare innovators and counts leading corporations and organizations among its clients and partners in delivering knowledge platforms in areas as diverse as pulmonary fibrosis, chronic kidney disease, uterine fibroids, and glaucoma. Clients and partners of Responsum Health include Astellas, Otsuka, Abbvie, Galapagos, the Allergan Foundation, Prevent Blindness, the Pulmonary Fibrosis Foundation, The White Dress Project, the Black Women’s Health Imperative, and CARE About Fibroids.

Leave a Reply

Your email address will not be published. Required fields are marked *